ecteinascidin 743 has been researched along with Mediastinal Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Decoupigny, E; Isambert, N; Le Cesne, A; Penel, N; Taieb, S; Tresch-Bruneel, E | 1 |
1 other study(ies) available for ecteinascidin 743 and Mediastinal Neoplasms
| Article | Year |
|---|---|
Exceptional Long-lasting Clinical Benefit of Trabectedin in a Patient With Metastatic Undifferentiated Pleomorphic Sarcoma: Postscriptum From the T-Dis Trial.
Topics: Antineoplastic Agents, Alkylating; Clinical Trials as Topic; Female; Histiocytoma, Malignant Fibrous; Humans; Mediastinal Neoplasms; Middle Aged; Prognosis; Retroperitoneal Neoplasms; Sarcoma; Trabectedin | 2019 |